The Venture Codex

Led · Equity · Apr 2026

Axis Finance provides lending across retail, MSME and wholesale segments. The company reported a business book of Rs 47,692 crore at the end of March, a 22% increase year-on-year, and posted a net profit of Rs 806 crore, up 19% year-on-year. It has undertaken its first external capital raise, securing Rs 750 crore from Kedaara Capital via a preferential issuance. Prior to this, Axis Bank infused Rs 1,500 crore into the company. The new capital is intended to bolster the firm’s capital base and fuel its growth and expansion. Kedaara’s investment remains subject to customary regulatory approvals.

Participated · Equity · Jan 2026

Avanse Financial Services operates as an education-centric NBFC, offering student loans and funding for educational infrastructure across a broad range of courses and geographies. The company positions itself as a technology-driven lender committed to enabling academic aspirations through responsible financing. Its current portfolio spans education loans for individuals as well as institutional financing for schools and colleges. Avanse plans to introduce new products such as flexi-term loans and receivable-financing term loans to serve additional white-space opportunities in the sector. Management is also investing in digital platform enhancements and deeper institutional partnerships to extend its reach and efficiency. The latest capital injection is intended to scale loan disbursements, drive product innovation, and strengthen the firm’s capital adequacy and balance-sheet resilience.

Participated · Equity · Dec 2025

ICICI Prudential AMC is the asset-management subsidiary of ICICI Bank, partnering with UK-based Prudential Corporation Holdings. The firm manages a diversified suite of mutual funds and other investment products for retail and institutional clients. To prepare for a public listing, the company completed a sizeable pre-IPO round and has now set a ₹2,061–2,165 per-share price band for its upcoming ₹10,602-crore initial public offering, which will run from 12-16 December with listing expected on 19 December. The planned IPO is structured entirely as an offer-for-sale of over 4.89 crore shares by Prudential, so the company itself will not receive those proceeds. The pre-IPO equity placement valued the AMC at roughly ₹1.07 lakh crore (US $11.9 billion), highlighting strong investor demand. Post-placement, ICICI Bank increased its stake to 53 percent, while Prudential’s share will be correspondingly reduced ahead of the IPO. On listing, ICICI Prudential AMC will become the fifth asset-management firm and the fifth ICICI Group entity to trade on Indian exchanges.

Participated · Equity · Oct 2025

Founded in 1975, Studds Accessories designs, manufactures, markets, and sells two-wheeler helmets under its mass-market Studds line and its premium SMK line, alongside ancillary motorcycle gear such as luggage, gloves, rain suits, riding jackets, eyewear, and helmet locks. The company also contract-manufactures helmets for global brands like Jay Squared’s Daytona and O’Neal, distributing these products across Europe, the United States, and Australia. Studds exports to over 70 countries, giving it a broad international footprint in the Americas, Asia, and Europe while maintaining a significant domestic presence in India. Its customer base includes leading motorcycle OEMs such as Hero MotoCorp, Honda Cars India, Suzuki Motorcycle India, Eicher Motors’ Royal Enfield, and India Yamaha Motor, as well as institutional buyers like Central Police Canteens and the Canteen Stores Department. The firm is preparing for a ₹455 crore initial public offering priced between ₹557–585 per share, which implies a valuation of roughly ₹2,300 crore at the top end. Because the IPO is entirely an offer for sale, Studds itself will not receive any primary proceeds. The company recently completed an anchor investor allocation to bolster demand ahead of the listing.

Led · Equity · Sep 2025

Axtria develops agentic artificial intelligence, advanced data analytics, and cloud-based tools tailored to life-sciences companies worldwide. The company positions itself as a trusted partner that helps pharmaceutical and other life-sciences clients harness technology to improve decision-making and operational efficiency. Axtria’s platform leverages agentic AI, a branch of generative AI that can learn and adapt with minimal human input and is well-suited for repeatable industry tasks. Financially, Axtria first raised $2.5 million in a 2010 Series A round led by Sequoia Capital, and secured $150 million from Bain Capital Tech Opportunities in 2021, which valued the business at roughly $850 million and pushed its valuation above $1 billion. The company continues to attract sizable growth investments, underlining investor confidence in its industry-specific AI capabilities. No operating metrics such as revenue or user counts were disclosed in the article.